Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma

BACKGROUND: The second decade of this millennium was characterized by a widespread availability of chimeric antigen receptor T-cell (CAR-T) therapies to treat relapsed and refractory lymphomas. As expected, the role and indication of allogeneic haematopoietic stem cell transplant (allo-HSCT) in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Avenoso, Daniele, Alabdulwahab, Amal, Kenyon, Michelle, Mehra, Varun, Krishnamurthy, Pramila, Dazzi, Francesco, Leung, Ye Ting, Anteh, Sandra, Shah, Mili Naresh, Kuhnl, Andrea, Sanderson, Robin, Patten, Piers, Yallop, Deborah, Pagliuca, Antonio, Potter, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332350/
https://www.ncbi.nlm.nih.gov/pubmed/37435036
http://dx.doi.org/10.4084/MJHID.2023.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332350/
https://www.ncbi.nlm.nih.gov/pubmed/37435036
http://dx.doi.org/10.4084/MJHID.2023.041

Ejemplares similares